Printer Friendly
The Free Library
19,122,084 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Anulex Announces First U.S. Implantation of the Xclose(TM) Tissue Repair System.


MINNEAPOLIS -- Anulex Technologies, Inc. announced today the first U.S. procedure using a novel, new tissue repair device, the Xclose[TM] Tissue Repair System. The procedure was performed by Kenneth Yonemura, M.D., a neurosurgeon at the University of Utah The University of Utah (also The U or the U of U or the UU), located in Salt Lake City, is the flagship public research university in the state of Utah, and one of 10 institutions that make up the Utah System of Higher Education.  Medical Center in Salt Lake City, Utah For ships of the United States Navy of the same name, see .
Salt Lake City is the capital and the most populous city of the U.S. state of Utah. The name of the city is often shortened to Salt Lake, or its initials, S.L.C.
.

The Xclose[TM] Tissue Repair System provides a fast, simple, and safe way to re-approximate soft tissue defects. Dr. Yonemura commented, "The Xclose device provides an unique new method for treating the weakened tissue of the anulus fibrosus following a lumbar discectomy disc·ec·to·my
n.
The partial or complete excision of an intervertebral disk. Also called discotomy.
 procedure. Previously, we have not had a reliable method of closing the anulus and when it is not repaired, the material inside of the disc may re-extrude from the disc, compress the nerve root, and result in recurrent pain and reoperation."

The Xclose Tissue Repair System was first implanted outside of the U.S. by Dr. Guillermo Bajares in Caracas, Venezuela. The product received U.S. FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 510(k) clearance and represents the Company's second product offering in its soft tissue repair product family. Michael K. McCormick, President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Anulex Technologies, Inc. said, "The Xclose Tissue Repair System complements our Inclose in·close  
v.
Variant of enclose.

Verb 1. inclose - surround completely; "Darkness enclosed him"; "They closed in the porch with a fence"
shut in, close in, enclose
[TM] Surgical Mesh System to provide an expanded treatment option for soft tissue repair." McCormick went on to say, "The Company looks forward to expanding its U.S. distribution of the Xclose and Inclose Systems in 2007."

About Anulex

Anulex Technologies, Inc. is a privately held company privately held company

A firm whose shares are held within a relatively small circle of owners and are not traded publicly.
 dedicated to the development and commercialization of unique and proprietary soft tissue repair products with primary interests in treatments for the soft tissues of the spine. Back pain afflicts four out of every five individuals at some point during their life, and it is a major cause of disability. Founded in 2001, Anulex has dedicated itself to the development of devices to improve spine surgical outcomes.

Inclose, Xclose and Anulex are trademarks of Anulex Technologies, Inc.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 28, 2006
Words:314
Previous Article:Pinnacle Data Systems, Inc. to Acquire European Company.
Next Article:Peoples Bancorp Declares Cash Dividend.



Related Articles
Surgical mesh.
ORTEC SUCCESSFULY DEFENDS EUROPEAN PATENT ON ORCEL.
Articular cartilage injuries in the athlete's knee: current concepts in diagnosis and treatment.
Artificial urinary sphincter in high risk patients: assessment of patient satisfaction.
Cloning for dollars: morality & the market for stem cells.
Anulex Technologies Receives FDA 510(k) Clearance for the Inclose(TM) Surgical Mesh System.
BREAST RECONSTRUCTION STUDY INITIATED IN JAPAN.
Anulex Technologies, Inc. Raises $20 Million in Series C Financing.
INSERTING and REPLACING GORE DUALMESH(R) PLUS Biomaterial Inhibits Implant Infections by Drug-Resistant 'Superbugs' and Resists Biofilm Development.
FIRST HEART ATTACK PATIENT ENROLLED IN RAPID MI-ICE STUDY.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles